LON:C4XD - C4X Discovery Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 89.50 +1.00 (+1.13 %)
(As of 07/20/2018 04:00 PM ET)
Previous CloseGBX 89.50
Today's RangeGBX 87 - GBX 90
52-Week RangeGBX 67 - GBX 91.50
Volume13,478 shs
Average Volume2,983 shs
Market Capitalization£27.29 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
C4X Discovery Holdings plc operates as a drug discovery and development company in the United Kingdom. The company has a suite of proprietary technologies across the drug discovery process. The company's DNA-based target identification platform (Taxonomy3) utilizes human genetic datasets to identify novel patient-specific targets to discovery productivity and increase probability of clinical success. It also has novel drug design platform, which comprises two chemistry technologies, Conformetrix and Molplex that combine 4D molecular shape analyses with computational chemistry. This provides new and unprecedented insight into the behavior of drug molecules enabling the production of potent selective compounds. The company is advancing its in-house pipeline in addiction, diabetes, and inflammation with various new drug candidates identified and progress made towards the clinic. It has a strategic agreement with Evotec AG to develop new small molecule drugs across a range of targets, therapeutic areas, and stages of development with the programs targeted towards the treatment of cancer; and a research collaboration agreement with e-Therapeutics plc to identify mechanistic insights into Parkinson's Disease. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was founded in 2007 and is based in Manchester, the United Kingdom.

Receive C4XD News and Ratings via Email

Sign-up to receive the latest news and ratings for C4XD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolLON:C4XD
CUSIPN/A
Phone+44-161-2355085

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-5,761.54%
Return on Equity-98.87%
Return on Assets-87.87%

Miscellaneous

EmployeesN/A
Outstanding Shares46,560,000
Market Cap£27.29

C4X Discovery (LON:C4XD) Frequently Asked Questions

What is C4X Discovery's stock symbol?

C4X Discovery trades on the London Stock Exchange (LON) under the ticker symbol "C4XD."

What is the consensus analysts' recommendation for C4X Discovery?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for C4X Discovery in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of C4X Discovery's key competitors?

Who are C4X Discovery's key executives?

C4X Discovery's management team includes the folowing people:
  • Dr. Clive James Dix Ph.D., Chief Exec. Officer and Director (Age 63)
  • Mr. Bradley Richard Hoy, Chief Financial Officer and Director (Age 55)
  • Dr. Justian Craig Fox Ph.D., Chief Scientific Officer and Director (Age 43)
  • Ms. Bhavna Hunjan, Head of Corp. Strategy & Devel.
  • Mr. Mark James Sullivan, Company Sec.

Has C4X Discovery been receiving favorable news coverage?

Press coverage about C4XD stock has trended somewhat positive on Saturday, according to Accern. Accern rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. C4X Discovery earned a media sentiment score of 0.05 on Accern's scale. They also gave news articles about the company an impact score of 46.34 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of C4X Discovery?

Shares of C4XD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is C4X Discovery's stock price today?

One share of C4XD stock can currently be purchased for approximately GBX 89.50.

How big of a company is C4X Discovery?

C4X Discovery has a market capitalization of £27.29 million.

How can I contact C4X Discovery?

C4X Discovery's mailing address is 53 Portland Street, MANCHESTER, M1 3LD, United Kingdom. The company can be reached via phone at +44-161-2355085.


MarketBeat Community Rating for C4X Discovery (LON C4XD)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  86
MarketBeat's community ratings are surveys of what our community members think about C4X Discovery and other stocks. Vote "Outperform" if you believe C4XD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe C4XD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.